Neurotrophic effect of magnolol in the hippocampal CA1 region of Senescence-Accelerated Mice (SAMP1)

21Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Magnolol has neurotrophic effects in primary cultured rat cortical neurons, which are expressed as the promotion of neurite outgrowth and neuronal survival. In this study, we investigated the protective effect of magnolol against age-related neuronal loss in the hippocampus using senescence- accelerated mouse (SAMP1). Magnolol (5, 10 mg/kg) was orally administered once a day for 14 d to 2- or 4-month-old mice, and evaluation was carried out when the mice were 4 or 6 months old. The density of neurofibrils decreased with aging in the stratum radiatum of the CA1 region in the hippocampus of SAMP1, not SAMR1. Treatment with magnolol significantly prevented the decrease of neurofibrils in the CA1, when it was administered in 2-month-olds. However, administration at 4 months of age did not result in a preventive effect. These findings suggest that the administration of magnolol before the initiation of neuronal loss may result in a protective effect in the hippocampus. © 2005 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Matsui, N., Nakashima, H., Ushio, Y., Tada, T., Shirono, A., Fukuyama, Y., … Akagi, M. (2005). Neurotrophic effect of magnolol in the hippocampal CA1 region of Senescence-Accelerated Mice (SAMP1). Biological and Pharmaceutical Bulletin, 28(9), 1762–1765. https://doi.org/10.1248/bpb.28.1762

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free